Batch Production Record and Device History Record Review and Quality Assessment

Website http://www.onlinecompliancepanel.com?expDate=Ourglocal | Edit Freely

Category 508 compliance; act compliance; fda compliance; ada compliance; advisor compliance; argent software pci compliance; certificate of compliance; code compliance; compliance; compliance audit; compliance checklist; compliance issues; compliance jobs; compliance management; compliance manager; compliance manual; compliance monitoring; compliance monitoring ppt; compliance officer; compliance plan; compliance plans; compliance program; compliance software; compliance solutions; compliance testing; compliance training; compliance with; contract compliance; corporate compliance; email compliance; environmental compliance; export compliance; health care compliance; healthcare compliance; hipaa compliance; hippa compliance; investment advisor compliance; medical compliance; medication compliance; non compliance; osha compliance; osha compliance training; pci compliance; policy compliance; regulatory compliance; rohs compliance; safety compliance; sarbanes oxley compliance; security compliance; sox compliance; tax comp

Deadline: May 29, 2014 | Date: May 29, 2014

Venue/Country: 38868 Salmon Ter, Fremont, U.S.A

Updated: 2014-04-17 17:33:31 (GMT+9)

Call For Papers - CFP

Description:

Written procedures are to be established and followed for a time efficient and clear evidence of the quality related elements during the review and approval for release, including packaging and labeling, to determine compliance of the intermediates (FDA definition) and/or finished product with established specifications before a batch can be released for distribution.

BPRs, DHRs and laboratory control records for critical process steps are to be reviewed and approved by the quality unit(s) before a finished product batch is released for distribution. Production and laboratory control records for earlier, non-critical process steps may be reviewed by qualified production personnel or other units following procedures approved by the quality unit(s).

All incidents or deviations, investigation, and OOS, OOT, OOL reports should be reviewed to ensure there is no product quality impact by providing technically written sound scientific rationale for the assessment and conclusion as part of the batch record review before the batch is released.

Typical Elements Required to be Included in the Batch Production Record and the Device History Record in order to Accomplish a Quality and Cost Effective Review and Quality Assessment based on current Regulatory Expectations.

Why Should you Attend:

A vast majority of the current industry deficiencies which have led to isolated 483s, Warning Letters and Consent Decrees are the result of deficient technical documentation of the production processes for both injectables, devices and solid dosages.

Quality Systems require both Operations and Quality Departments to be unified with the overall intent of minimizing patient risk by documenting the process in a fashion that is technically accurate and easy to demonstrate that we are thinking and operating with the same objectives as the regulatory agencies are required to enforce.

Objectives of the Presentation:

Generation of BPRs, DHRs and SOPs to provide technically written instruction sets to eliminate operator errors. Training is NOT the primary means of generating and error free operation.

Production and In-Process Controls

Inspection, Packaging and Identification Labeling of Finished Products and Intermediates

Responsibilities for Production Activities

Data selection and entry into the statistical tracking from the BPR and DHR

Incident / Deviation Tracking along with Customer Complaints and CAPA changes

Annual Reports

Who can Benefit:

Quality and Documentation Personnel within the industry

http://www.onlinecompliancepanel.com/ecommerce/webinar/~product_id=500281?expDate=Ourglocal